Surgical Robots Market size was over USD 17.2 billion in 2026 and is likely to grow at a 14.16% CAGR between 2027 and 2036, reaching USD 64.66 billion by 2036. The industry revenue for 2027 is assessed at USD 19.25 billion.
Increasing adoption of robotic-assisted procedures will drive the surgical robots market as hospitals seek technologies that can improve instrument control, visualization, and precision during complex operations. Robotic platforms provide surgeons with enhanced maneuverability and stable instrument movement, which can support minimally invasive approaches across multiple specialties. Improved workflow capabilities and the potential for more consistent surgical execution are also encouraging healthcare providers to incorporate robotic systems into operating room infrastructure where appropriate.
Growing demand for orthopedic and joint replacement procedures will propel the surgical robots market as healthcare providers increasingly adopt technology designed to support precise bone preparation and implant positioning. Robotic-assisted orthopedic systems can use detailed anatomical information and intraoperative guidance to help surgeons plan and execute procedures according to patient-specific requirements. As the volume and complexity of orthopedic interventions increase, hospitals are evaluating advanced robotic platforms that can support greater procedural control and integration with modern surgical workflows.
Expanding investment in automated surgical instruments will strengthen the surgical robots market by improving the range of functions that can be performed through robotic-assisted platforms. Advanced instruments with improved articulation, control, sensing, and automation capabilities can support surgeons during increasingly complex procedures while enabling more sophisticated operating room workflows. Hospitals are also investing in supporting infrastructure, specialized instruments, and robotic-compatible equipment to build comprehensive surgical programs rather than relying solely on the core robotic platform.
| Growth Driver Assessment Framework | |||||
| Growth Driver | Impact On CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Increasing adoption of robotic-assisted surgeries improving procedural precision and operational efficiency | 2.00% | High | North America, Europe | High | Near Term |
| Rising orthopedic and joint replacement procedures accelerating demand for advanced surgical robotic systems | 1.80% | High | North America, Asia Pacific | High | Mid Term |
| Expanding investments in automated surgical instruments enhancing hospital robotic surgery capabilities | 1.50% | Moderate | Asia Pacific, Europe | Medium | Mid Term |
North America held the largest share of the surgical robots market at 53.45% in 2026, reflecting the region's advanced healthcare infrastructure, strong adoption of robotic-assisted procedures, and substantial investment in surgical technology. Hospitals are increasingly incorporating robotic platforms to support precision, minimally invasive techniques, and improved procedural efficiency across a range of specialties. Strong clinical expertise, favorable healthcare investment conditions, and growing acceptance of technology-enabled surgery continue to reinforce the region's leadership.
Asia Pacific is experiencing the fastest growth as healthcare systems expand their adoption of advanced surgical technologies and hospitals invest in modern operating infrastructure. Rising demand for minimally invasive procedures, increasing healthcare expenditure, and improvements in specialist training are creating a supportive environment for robotic surgery. Growing medical tourism activity in selected markets and broader access to sophisticated healthcare technologies are further contributing to regional expansion.
The U.S. surgical robots market benefits from strong investment in minimally invasive procedures and continuous hospital technology upgrades. Healthcare providers increasingly evaluate robotic platforms based on clinical workflow efficiency, surgeon training, and procedural versatility across multiple specialties.
Japan encourages the adoption of surgical robots through healthcare modernization and demand for precise minimally invasive procedures. Hospitals increasingly prioritize systems that enhance operational efficiency while supporting consistent surgical performance across complex interventions.
South Korea strengthens its surgical robots market through advanced healthcare infrastructure and active integration of digital operating room technologies. The country supports collaborative innovation between healthcare providers and medical technology developers to expand robotic surgical capabilities.
Germany supports surgical robot adoption through technologically advanced hospitals seeking precision, workflow optimization, and improved surgical outcomes. The country places significant emphasis on integrating robotic systems into established clinical infrastructure and specialist training programs.
France emphasizes the clinical evaluation and responsible deployment of surgical robotics within specialized healthcare centers. Hospitals increasingly focus on technologies that improve procedural consistency, support surgeon expertise, and complement minimally invasive treatment strategies.
Italy expands surgical robot utilization through specialized hospitals seeking greater precision in complex surgical procedures. Healthcare institutions increasingly invest in robotic platforms that strengthen multidisciplinary care while improving procedural efficiency and patient management.
The inpatient segment led the surgical robots market in 2026, accounting for a 55.79% share, supported by the concentration of complex surgical procedures and advanced robotic infrastructure within hospitals. Inpatient settings provide access to specialized surgical teams, comprehensive perioperative services, advanced imaging, and postoperative monitoring, making them well suited for robot-assisted procedures that require extensive clinical support. The growing adoption of minimally invasive techniques and increasing demand for precision, consistency, and improved surgical control continue to reinforce the use of robotic systems in hospital-based care.
Outpatient settings are gaining momentum as advances in surgical robotics enable more procedures to be performed with shorter recovery periods and reduced hospitalization requirements. The increasing preference for minimally invasive interventions, combined with improvements in robotic precision and workflow efficiency, is supporting the adoption of robotic systems in ambulatory environments. As healthcare providers seek to improve operating efficiency, reduce inpatient resource utilization, and accommodate patient preferences for same-day or shorter-stay procedures, outpatient applications are positioned for rapid expansion.
Holding the largest share of the surgical robots market in 2026, the urology segment accounted for 29.64%, reflecting the strong suitability of robotic systems for procedures requiring precise manipulation within anatomically complex areas. Robot-assisted techniques provide surgeons with enhanced visualization, dexterity, and control, supporting their use across a broad range of urological interventions. Increasing adoption of minimally invasive approaches and the emphasis on precision in delicate procedures continue to sustain demand for robotic platforms in urology.
Orthopedics represents the fastest-growing application as robotic assistance becomes increasingly valuable in procedures requiring accurate positioning, alignment, and reproducible surgical execution. Robotic technologies can support surgeons in planning and performing complex orthopedic interventions while improving procedural precision and enabling more personalized approaches. Growing demand for minimally invasive treatment, rising emphasis on surgical accuracy, and continued advancement of image-guided and navigation-enabled systems are contributing to stronger adoption of robotics across orthopedic procedures.
| Report Segmentation | |||
| Segment | Sub-Segment | Largest Segment | Fastest Growing Segment |
|---|---|---|---|
| End-use | Inpatient, Outpatient | Inpatient | Outpatient |
| Application | Orthopedics, Neurology, Urology, Gynecology, Others | Urology | Orthopedics |
1. Intuitive Surgical Inc. (United States)
2. Medtronic plc (Ireland)
3. Stryker Corporation (United States)
4. Smith & Nephew plc (United Kingdom)
5. Zimmer Biomet Holdings Inc. (United States)
6. Asensus Surgical Inc. (United States)
7. CMR Surgical Ltd. (United Kingdom)
8. Johnson & Johnson (United States)
9. MicroPort MedBot (China)
10. Renishaw plc (United Kingdom)
The surgical robots market is characterized by continuous technological advancement aimed at improving surgical precision, procedural flexibility, and clinical efficiency. Companies are increasing investments in robotic visualization systems, automation capabilities, and minimally invasive surgical applications to strengthen their competitive positions. Expanding procedure compatibility and enhanced surgeon assistance technologies are also shaping innovation trends within the surgical robots market.
| Company Name | Date | Key Development |
|---|---|---|
| KARL STORZ | Aug-24 | KARL STORZ finalized its acquisition of Asensus Surgical to form a dedicated performance-guided surgical robotics hub. This transaction accelerates the integration of digital capabilities into its minimally invasive instrument portfolio, altering competitive positioning in the soft-tissue robotic market. |
| Cornerstone Robotics | Nov-25 | Cornerstone Robotics closed an oversubscribed 200 million dollar funding round to support the global expansion of its surgical robotics technologies. The capital injection accelerates the commercialization and international scaling of its competitive robotic surgery systems, increasing capital intensity within the market. |
| Intuitive Surgical | Mar-26 | Intuitive Surgical expanded its European footprint by acquiring distribution businesses for its da Vinci and Ion platforms. This transaction consolidates direct market access across multiple countries including Italy, Spain, and Portugal, improving operational control and scaling regional commercialization. |
| CMR Surgical | Mar-26 | CMR Surgical entered into an AI development partnership with NVIDIA, contributing surgical data to Open-H, the world's largest open robotics dataset. The collaboration aims to train and accelerate the deployment of next-generation AI-powered robotic systems, driving technological transformation. |
| Banner Health | Feb-26 | Banner Health scaled its operational footprint by deploying a fleet of 49 da Vinci 5 surgical systems from Intuitive Surgical. This large-scale infrastructure upgrade increases institutional capacity and procedural throughput, reinforcing hospital-led demand for next-generation robotic platforms. |
| Medtronic | Sep-24 | Medtronic partnered with Siemens Healthineers to integrate advanced robotic X-ray imaging capabilities into its spine surgery ecosystem. This strategic integration enhances image-guided workflow efficiencies and precision during minimally invasive orthopedic interventions, strengthening its competitive market positioning. |
| Meril | Jun-24 | Meril launched its indigenously developed MISSO surgical robot for knee replacement surgeries, reducing institutional capital requirements by 66% compared to imported platforms. The CDSCO-approved system targets greater financial accessibility in smaller hospital networks while awaiting CE and USFDA clearances. |
| SS Innovations | Jun-25 | SS Innovations expanded its international presence by completing its first robotic cardiac surgery in the Americas using the SSi Mantra 3 system in Ecuador. This footprint expansion supports its global commercial strategy as the company targets USFDA clearance. |
| Johnson & Johnson | May-26 | Johnson & Johnson released positive clinical data for its OTTAVA soft-tissue robotic surgical platform following successful gastric bypass procedures. The milestone validates the platform's multi-specialty clinical utility as the company advances commercialization plans for the soft-tissue segment. |
| Care Hospitals | Jul-25 | Care Hospitals expanded its robotic orthopedic program by integrating the AI-driven Stryker Mako Robotic System in Hyderabad. The deployment leverages 3D CT-based planning and real-time guidance to scale high-precision, minimally invasive joint replacement capacity. |